MAIA Biotechnology
agreement announces clinical supply with for phase clinical trial evaluating thio in sequential administration with in advanced non small cell lung cancer | MAIA Biotechnology
Company
Deck Type
Sector
Industry
Deck date
October 2023
Slide
11 of 39
Similar slides by MAIA Biotechnology
See diffirences between slides (animation)
Investor Presentation
January 2024
agreement | MAIA Biotechnology
Investor Presentation
November 2023
agreement announces clinical supply with for phase clinical trial evaluating thio in sequential administration with in advanced non small cell lung cancer | MAIA Biotechnology
Investor Presentation
July 2023
agreement | MAIA Biotechnology
Other recent decks by MAIA Biotechnology
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
November 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights